Recommendations on the use and reporting of race, ethnicity, and ancestry in genetic research: experiences from the NHLBI Trans-Omics for Precision Medicine (TOPMed) program

Abstract: The ways in which race, ethnicity, and ancestry are used and reported in human genomics research has wide-ranging implications for how research is translated into clinical care, incorporated into public understanding, and implemented in public policy. Genetics researchers play an essential role in proactively dismantling genetic conceptions of race and in recognizing the social and structural factors that drive health disparities. Here, we offer commentary and concrete recommendations on the use and reporting of race, ethnicity, and ancestry across the arc of genetic research, including terminology, data harmonization, analysis, and reporting. While informed by our experiences as researchers in the NHLBI Trans-Omics for Precision Medicine (TOPMed) program, the recommendations are broadly applicable to basic and translational genomic research in diverse populations. To fully realize the benefit of diversifying genetics research beyond primarily European ancestry populations, we as genetics researchers need to make structural changes to the research process and within the research community. Considerable collaborative effort and ongoing reflection will be required to root out elements of racism from the field and generate scientific knowledge that yields broad and equitable benefit.